[Invasive bladder cancer recurrenced 5 years after complete response status by chemotherapy and radiotherapy: a case report]

Hinyokika Kiyo. 2005 Nov;51(11):755-7.
[Article in Japanese]

Abstract

A 72-year-old man had undergone trasucethral resection of bladder tumor (TUR-Bt) three times from 1990 to 1991 and he had been lost to follow with no recurrence from 1996, came to our hospital complaining of asymptomatic macrohematuria in May 1999. A bladder tumor existed around the right ureteral orifice with right hydronephrosis. MRI and TUR-Bt revealed that the cancer was transitional cell carcinoma (TCC) > small cell carcinoma, G3, pT3b. Because the patient insisted on bladder preservation, intra arterial chemotherapy with cisplatinum (CDDP) and epirubicin (EPI-adr) followed by radiotherapy with CDDP was performed. The treatment resulted in a clinical complete response (CR), and the bladder was preserved. In January 2004, an invasive bladder cancer recurred at the left lateral wall. This time, neoadjuvant intra-arterial chemotherapy with CDDP and EPI-adr, followed by radical cystectomy was performed. Histologically, the recurrent bladder cancer was TCC, G3, pT3b.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Transitional Cell / drug therapy
  • Carcinoma, Transitional Cell / radiotherapy
  • Carcinoma, Transitional Cell / surgery*
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Cystectomy*
  • Epirubicin / administration & dosage
  • Humans
  • Neoplasm Recurrence, Local / surgery*
  • Remission Induction
  • Time Factors
  • Urinary Bladder Neoplasms / drug therapy
  • Urinary Bladder Neoplasms / radiotherapy
  • Urinary Bladder Neoplasms / surgery*

Substances

  • Epirubicin
  • Cisplatin